Skip to main content

Closed

CMPX: Compass Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-38.3%

Financially safe

Stretched

Debt / equity0.05×

Interest coverage0.0×

Current ratio19.04×

Compass Therapeutics, Inc.

CMPXNASDAQ Capital Market·USD·Closed

Compass Therapeutics, Inc.

CMPXNASDAQ·USD·Closed

$1.91

−1.55%

$1.91

−$0.03 (1.55%)

52W Range

6thpctl

Volume

0.62×avg

Mkt Cap

343.97MUSD

P/E

-4.5TTM

Div Yield

–ann

52W Range

6thpctl

Volume

0.62×avg

Market Cap

343.97MUSD

P/E Ratio

-4.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings